US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
DE3650699T2
(de)
|
1985-03-15 |
1999-04-15 |
Antivirals Inc |
Immunotestmittel für Polynukleotid und Verfahren
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
US5569597A
(en)
|
1985-05-13 |
1996-10-29 |
Ciba Geigy Corp. |
Methods of inserting viral DNA into plant material
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
US5268463A
(en)
|
1986-11-11 |
1993-12-07 |
Jefferson Richard A |
Plant promoter α-glucuronidase gene construct
|
US5608142A
(en)
|
1986-12-03 |
1997-03-04 |
Agracetus, Inc. |
Insecticidal cotton plants
|
US5023179A
(en)
|
1988-11-14 |
1991-06-11 |
Eric Lam |
Promoter enhancer element for gene expression in plant roots
|
US5110732A
(en)
|
1989-03-14 |
1992-05-05 |
The Rockefeller University |
Selective gene expression in plants
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
DE69133128T2
(de)
|
1990-04-12 |
2003-06-18 |
Syngenta Participations Ag |
Gewebe-spezifische Promotoren
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5498830A
(en)
|
1990-06-18 |
1996-03-12 |
Monsanto Company |
Decreased oil content in plant seeds
|
US5459252A
(en)
|
1991-01-31 |
1995-10-17 |
North Carolina State University |
Root specific gene promoter
|
US5399680A
(en)
|
1991-05-22 |
1995-03-21 |
The Salk Institute For Biological Studies |
Rice chitinase promoter
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
CA2116449C
(en)
|
1991-08-27 |
2005-04-05 |
Vaughan Alan Hilder |
Proteins with insecticidal properties against homopteran insects and their use in plant protection
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
DE69233410D1
(de)
|
1991-10-04 |
2004-10-21 |
Univ North Carolina State |
Pathogenresistente transgene pflanzen
|
US5428148A
(en)
|
1992-04-24 |
1995-06-27 |
Beckman Instruments, Inc. |
N4 - acylated cytidinyl compounds useful in oligonucleotide synthesis
|
US5401836A
(en)
|
1992-07-16 |
1995-03-28 |
Pioneer Hi-Bre International, Inc. |
Brassica regulatory sequence for root-specific or root-abundant gene expression
|
US5650298A
(en)
|
1993-06-14 |
1997-07-22 |
Basf Aktiengesellschaft |
Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
|
US5814618A
(en)
|
1993-06-14 |
1998-09-29 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
US5789156A
(en)
|
1993-06-14 |
1998-08-04 |
Basf Ag |
Tetracycline-regulated transcriptional inhibitors
|
US5633363A
(en)
|
1994-06-03 |
1997-05-27 |
Iowa State University, Research Foundation In |
Root preferential promoter
|
US5608144A
(en)
|
1994-08-12 |
1997-03-04 |
Dna Plant Technology Corp. |
Plant group 2 promoters and uses thereof
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
CA2200952C
(en)
|
1994-09-30 |
2006-04-11 |
Inex Pharmaceuticals Corp. |
Novel compositions comprising quaternary ammonium compounds and neutral lipids for the introduction of polyanionic materials into cells
|
US5753613A
(en)
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
US5659026A
(en)
|
1995-03-24 |
1997-08-19 |
Pioneer Hi-Bred International |
ALS3 promoter
|
IL122290A0
(en)
|
1995-06-07 |
1998-04-05 |
Inex Pharmaceuticals Corp |
Lipid-nucleic acid complex its preparation and use
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5705385A
(en)
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
US5856174A
(en)
|
1995-06-29 |
1999-01-05 |
Affymetrix, Inc. |
Integrated nucleic acid diagnostic device
|
US5837876A
(en)
|
1995-07-28 |
1998-11-17 |
North Carolina State University |
Root cortex specific gene promoter
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US20040171031A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US6072050A
(en)
|
1996-06-11 |
2000-06-06 |
Pioneer Hi-Bred International, Inc. |
Synthetic promoters
|
US5874554A
(en)
|
1996-12-13 |
1999-02-23 |
Incyte Pharmaceuticals, Inc. |
Methods and solvent vehicles for reagent delivery in oligonucleotide synthesis using automated pulse jetting devices
|
DE69841002D1
(de)
|
1997-05-14 |
2009-09-03 |
Univ British Columbia |
Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
|
AU8428998A
(en)
|
1997-07-24 |
1999-02-16 |
Inex Pharmaceuticals Corporation |
Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
EP1056862A1
(en)
|
1998-02-26 |
2000-12-06 |
Pioneer Hi-Bred International, Inc. |
Family of maize pr-1 genes and promoters
|
AR014072A1
(es)
|
1998-02-26 |
2001-01-31 |
Pioneer Hi Bred Int |
Molecula de acido nucleico aislada que tiene una secuencia nucleotidica para un promotor que es capaz de iniciar una transcripcion constitutiva en unacelula de planta, construccion adn, vector, celula huesped, metodo para expresar en forma constitutiva una secuencia nucleotidica heteroloca en una
|
US6218181B1
(en)
|
1998-03-18 |
2001-04-17 |
The Salk Institute For Biological Studies |
Retroviral packaging cell line
|
DE69928264T2
(de)
|
1998-08-20 |
2006-07-13 |
Pioneer Hi-Bred International, Inc. |
Samen-bevorzugende promotoren
|
WO2000012733A1
(en)
|
1998-08-28 |
2000-03-09 |
Pioneer Hi-Bred International, Inc. |
Seed-preferred promoters from end genes
|
AU2291700A
(en)
|
1999-01-19 |
2000-08-07 |
Unilever Plc |
Method for producing antibody fragments
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
WO2000062813A2
(en)
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
NZ514348A
(en)
|
1999-05-04 |
2004-05-28 |
Exiqon As |
L-ribo-LNA analogues
|
EP1177306A2
(en)
|
1999-05-07 |
2002-02-06 |
E.I. Du Pont De Nemours And Company |
Plant defensins
|
US6770750B2
(en)
|
1999-11-18 |
2004-08-03 |
Korea Kumho Petrochemical Co., Ltd. |
Small and cysteine rich antifungal defensin and thionin-like protein genes highly expressed in the incompatible interaction
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
DE10100586C1
(de)
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
IL151928A0
(en)
|
2000-03-30 |
2003-04-10 |
Whitehead Biomedical Inst |
Rna sequence-specific mediators of rna interference
|
US7189705B2
(en)
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
JP4095895B2
(ja)
|
2000-12-01 |
2008-06-04 |
マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー.ヴェー. |
Rna干渉を媒介する短鎖rna分子
|
US7053150B2
(en)
|
2000-12-18 |
2006-05-30 |
Nektar Therapeutics Al, Corporation |
Segmented polymers and their conjugates
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
US7423142B2
(en)
|
2001-01-09 |
2008-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US7767802B2
(en)
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
WO2002087541A1
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Lipid-based formulations for gene transfer
|
US20070270579A1
(en)
|
2001-05-18 |
2007-11-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20070173473A1
(en)
|
2001-05-18 |
2007-07-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of proprotein convertase subtilisin Kexin 9 (PCSK9) gene expression using short interfering nucleic acid (siNA)
|
US20050196781A1
(en)
|
2001-05-18 |
2005-09-08 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of STAT3 gene expression using short interfering nucleic acid (siNA)
|
US20050191618A1
(en)
|
2001-05-18 |
2005-09-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
|
EP2270188A3
(en)
|
2001-06-22 |
2011-09-07 |
Pioneer Hi-Bred International, Inc. |
Defensin polynucleotides and methods of use
|
CN1555413A
(zh)
|
2001-07-13 |
2004-12-15 |
�ȷ�����ֹ��ʹɷ�����˾ |
维管组织优选的启动子
|
PT2280070E
(pt)
|
2001-07-23 |
2015-10-29 |
Univ Leland Stanford Junior |
Métodos e composições para inibição mediada por iarn da expressão génica em mamíferos
|
US10590418B2
(en)
|
2001-07-23 |
2020-03-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for RNAi mediated inhibition of gene expression in mammals
|
US20030106097A1
(en)
|
2001-07-30 |
2003-06-05 |
Haigler Candace H. |
Chitinase encoding DNA molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter
|
WO2003020739A2
(en)
|
2001-09-04 |
2003-03-13 |
Exiqon A/S |
Novel lna compositions and uses thereof
|
DE10163098B4
(de)
|
2001-10-12 |
2005-06-02 |
Alnylam Europe Ag |
Verfahren zur Hemmung der Replikation von Viren
|
US7745418B2
(en)
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
DE10202419A1
(de)
|
2002-01-22 |
2003-08-07 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines durch eine Chromosomen-Aberration entstandenen Zielgens
|
KR100464261B1
(ko)
|
2002-01-24 |
2005-01-03 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
US20100240730A1
(en)
|
2002-02-20 |
2010-09-23 |
Merck Sharp And Dohme Corp. |
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
|
KR20030084444A
(ko)
|
2002-04-26 |
2003-11-01 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
ATE485031T1
(de)
|
2002-06-28 |
2010-11-15 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
AU2003282722A1
(en)
|
2002-10-02 |
2004-04-23 |
Alnylam Pharmaceuticals Inc. |
Therapeutic compositions
|
US20060035344A1
(en)
|
2002-10-18 |
2006-02-16 |
Pachuk Catherine J |
Double-stranded rna structures and constructs, and methods for generating and using the same
|
JP2004261002A
(ja)
|
2003-01-08 |
2004-09-24 |
Tsutomu Suzuki |
siRNAの製造方法
|
WO2004064737A2
(en)
|
2003-01-17 |
2004-08-05 |
Alnylam Pharmaceuticals |
Therapeutics compositions
|
CA2518475C
(en)
|
2003-03-07 |
2014-12-23 |
Alnylam Pharmaceuticals, Inc. |
Irna agents comprising asymmetrical modifications
|
US20050233342A1
(en)
|
2003-03-07 |
2005-10-20 |
Muthiah Manoharan |
Methods of preventing off-target gene silencing
|
WO2004090108A2
(en)
|
2003-04-03 |
2004-10-21 |
Alnylam Pharmaceuticals |
Irna conjugates
|
EP1631669A2
(en)
|
2003-04-09 |
2006-03-08 |
Biodelivery Sciences International, Inc. |
Cochleate compositions directed against expression of proteins
|
CA2521464C
(en)
|
2003-04-09 |
2013-02-05 |
Alnylam Pharmaceuticals, Inc. |
Irna conjugates
|
US20070179100A1
(en)
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
CA2522349A1
(en)
|
2003-04-17 |
2004-11-04 |
Alnylam Pharmaceuticals, Inc. |
Protected monomers
|
EP1620544B1
(en)
|
2003-04-17 |
2018-09-19 |
Alnylam Pharmaceuticals Inc. |
MODIFIED iRNA AGENTS
|
US7595306B2
(en)
|
2003-06-09 |
2009-09-29 |
Alnylam Pharmaceuticals Inc |
Method of treating neurodegenerative disease
|
EP1635763B1
(en)
|
2003-06-09 |
2012-08-08 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
ES2905724T3
(es)
|
2003-06-13 |
2022-04-11 |
Alnylam Europe Ag |
Acido ribonucleico bicatenario con elevada eficacia en un organismo
|
US7211668B2
(en)
|
2003-07-28 |
2007-05-01 |
Panagene, Inc. |
PNA monomer and precursor
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
JP2007505925A
(ja)
|
2003-09-17 |
2007-03-15 |
レット ゼア ビー ホープ メディカル リサーチ インスティチュート |
骨髄性およびリンパ様免疫細胞への薬物の送達のための標的化脂質薬物製剤
|
EP1689414A4
(en)
*
|
2003-12-04 |
2009-04-08 |
Univ South Florida Res Foundat |
POLYNUCLEOTIDES FOR REDUCING GENE EXPRESSION OF THE RESPIRATORY SYNCYTIAL VIRUS
|
EP2365077B1
(en)
|
2004-03-12 |
2013-05-08 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeting VEGF
|
JP2007531794A
(ja)
|
2004-04-05 |
2007-11-08 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
オリゴヌクレオチドの合成および精製に使用する方法および反応試薬
|
EP1768998A2
(en)
|
2004-04-27 |
2007-04-04 |
Alnylam Pharmaceuticals Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
EP3034510A1
(en)
|
2004-04-30 |
2016-06-22 |
Alnylam Pharmaceuticals Inc. |
Oligonucleotides comprising a c5-modified pyrimidine
|
EP2399924B1
(en)
|
2004-05-27 |
2015-01-28 |
Alnylam Pharmaceuticals, Inc. |
Nuclease resistant double-stranded ribonucleic acid
|
WO2005115471A2
(en)
|
2004-05-27 |
2005-12-08 |
Neurocure Ltd. |
Methods and compositions for treatment of nicotine dependence and dementias
|
US7745651B2
(en)
|
2004-06-07 |
2010-06-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
US7799565B2
(en)
|
2004-06-07 |
2010-09-21 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering RNA
|
US7615618B2
(en)
|
2004-06-30 |
2009-11-10 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
US20080213891A1
(en)
|
2004-07-21 |
2008-09-04 |
Alnylam Pharmaceuticals, Inc. |
RNAi Agents Comprising Universal Nucleobases
|
US7579451B2
(en)
|
2004-07-21 |
2009-08-25 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
US7632932B2
(en)
|
2004-08-04 |
2009-12-15 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
|
WO2006020768A2
(en)
|
2004-08-10 |
2006-02-23 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides
|
AU2005289588B2
(en)
|
2004-09-24 |
2011-12-22 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of ApoB and uses thereof
|
WO2006073602A2
(en)
|
2004-11-24 |
2006-07-13 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of the bcr-abl fusion gene and uses thereof
|
WO2006063252A2
(en)
|
2004-12-09 |
2006-06-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
|
AU2005316384B2
(en)
|
2004-12-14 |
2012-02-09 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of MLL-AF4 and uses thereof
|
EP3372676A1
(en)
|
2004-12-21 |
2018-09-12 |
Monsanto Technology, LLC |
Recombinant dna constructs and methods for controlling gene expression
|
DE602005019324D1
(de)
|
2004-12-29 |
2010-03-25 |
Applied Biosystems Llc |
Einander ergänzender polynukleotide
|
CA2594334A1
(en)
|
2005-01-07 |
2006-07-13 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of rsv and therapeutic uses thereof
|
US20060217324A1
(en)
|
2005-01-24 |
2006-09-28 |
Juergen Soutschek |
RNAi modulation of the Nogo-L or Nogo-R gene and uses thereof
|
US7718625B2
(en)
|
2005-01-27 |
2010-05-18 |
University Of South Florida |
Polynucleotides targeted against the extended 5′-UTR region of argininosuccinate synthase and uses thereof
|
WO2006084209A2
(en)
|
2005-02-03 |
2006-08-10 |
Benitec, Inc. |
Rnai expression constructs
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
CA2597724A1
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
US7737265B2
(en)
|
2005-06-27 |
2010-06-15 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of HIF-1 and therapeutic uses thereof
|
US20070044161A1
(en)
|
2005-07-21 |
2007-02-22 |
Juergen Soutschek |
RNAi modulation of the Rho-A gene in research models
|
AU2006274413B2
(en)
|
2005-07-27 |
2013-01-10 |
Arbutus Biopharma Corporation |
Systems and methods for manufacturing liposomes
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
CA2618995A1
(en)
|
2005-08-10 |
2007-02-22 |
The Rockefeller University |
Antagomirs for use in inhibiting mir-122
|
US20100136614A1
(en)
*
|
2005-10-18 |
2010-06-03 |
Dan Luo |
Dendrimer-like modular delivery vector
|
US20070148246A1
(en)
|
2005-08-11 |
2007-06-28 |
Dan Luo |
Nucleic Acid-Based Matrixes
|
WO2007022470A2
(en)
|
2005-08-18 |
2007-02-22 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for treating neurological disease
|
CA2627025A1
(en)
|
2005-10-28 |
2007-05-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of huntingtin gene
|
US20070197460A1
(en)
|
2005-11-01 |
2007-08-23 |
Alnylam Pharmaceuticals, Inc. |
Rnai inhibition of influenza virus replication
|
CA2626584A1
(en)
|
2005-11-04 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of nav1.8 gene
|
EP2363134B1
(en)
|
2005-11-09 |
2014-01-08 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of factor V Leiden mutant gene
|
CA2527144C
(en)
|
2005-11-15 |
2014-04-29 |
Queen's University At Kingston |
Reversibly switchable surfactants and methods of use thereof
|
BRPI0618907A2
(pt)
|
2005-11-25 |
2012-04-17 |
Mologen Ag |
c0nstructo de expressão de dna, método de produção de vetores, kit para produção de vetores e para produção de constructo de expressão
|
US8362229B2
(en)
|
2006-02-08 |
2013-01-29 |
Quark Pharmaceuticals, Inc. |
Tandem siRNAS
|
US7846908B2
(en)
|
2006-03-16 |
2010-12-07 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of TGF-beta and therapeutic uses thereof
|
SG170780A1
(en)
|
2006-03-31 |
2011-05-30 |
Alnylam Pharmaceuticals Inc |
Compositions and methods for inhibiting expression of eg5 gene
|
US7691824B2
(en)
|
2006-04-28 |
2010-04-06 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a gene from the JC virus
|
DK2024499T3
(da)
|
2006-05-10 |
2018-01-29 |
Sarepta Therapeutics Inc |
Oligonukleotidanaloger med kationiske intersubunit-koblinger
|
ES2874149T3
(es)
|
2006-05-11 |
2021-11-04 |
Alnylam Pharmaceuticals Inc |
Composiciones y métodos para inhibir la expresión del gen PCSK9
|
AU2007249488B2
(en)
|
2006-05-15 |
2011-11-10 |
Immunonomedics, Inc. |
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
|
CA2653052A1
(en)
|
2006-05-19 |
2007-11-29 |
The Scripps Research Institute |
Treatment of protein misfolding
|
CA2652770A1
(en)
|
2006-05-19 |
2007-11-29 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of aha and therapeutic uses thereof
|
US7888498B2
(en)
|
2006-05-22 |
2011-02-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of IKK-B gene
|
WO2008008719A2
(en)
|
2006-07-10 |
2008-01-17 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the myc gene
|
US20080039415A1
(en)
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
JP5431940B2
(ja)
|
2006-09-18 |
2014-03-05 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
SCAPのRNAi調節およびその治療的使用
|
AU2007299629C1
(en)
|
2006-09-21 |
2012-05-10 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the HAMP gene
|
US7906484B2
(en)
|
2006-09-21 |
2011-03-15 |
Alnylam Pharmaceuticals, Inc. |
Complex for transferring an anionic substance into a cell
|
MX2009003548A
(es)
|
2006-10-03 |
2009-04-15 |
Alnylam Pharmaceuticals Inc |
Formulaciones que contienen lipidos.
|
WO2008049078A1
(en)
|
2006-10-18 |
2008-04-24 |
Nastech Pharmaceutical Company Inc. |
Nicked or gapped nucleic acid molecules and uses thereof
|
US8034921B2
(en)
|
2006-11-21 |
2011-10-11 |
Alnylam Pharmaceuticals, Inc. |
IRNA agents targeting CCR5 expressing cells and uses thereof
|
AP2014007971A0
(en)
|
2007-03-29 |
2014-09-30 |
Alnylam Pharmaceuticals Inc |
Compositions and methods for inhibiting expressionof a gene from the ebola
|
US8877917B2
(en)
|
2007-04-23 |
2014-11-04 |
Alnylam Pharmaceuticals, Inc. |
Glycoconjugates of RNA interference agents
|
US20110250138A1
(en)
|
2007-08-01 |
2011-10-13 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligand
|
CA2884340C
(en)
|
2007-11-15 |
2017-07-25 |
Sarepta Therapeutics, Inc. |
Method of synthesis of morpholino oligomers
|
WO2009082607A2
(en)
|
2007-12-04 |
2009-07-02 |
Alnylam Pharmaceuticals, Inc. |
Targeting lipids
|
US20110159586A1
(en)
|
2007-12-07 |
2011-06-30 |
Halo-Bio Rnai Therapeutics, Inc. |
Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
|
WO2009086558A1
(en)
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
WO2009127060A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
JP5642673B2
(ja)
|
2008-07-10 |
2014-12-17 |
セリナ・セラピユーテイツクス・インコーポレーテツド |
不活性末端基を有するポリオキサゾリン類、保護された開始基から調製されるポリオキサゾリン類及び関連化合物
|
US9139554B2
(en)
|
2008-10-09 |
2015-09-22 |
Tekmira Pharmaceuticals Corporation |
Amino lipids and methods for the delivery of nucleic acids
|
US8298765B2
(en)
|
2009-01-01 |
2012-10-30 |
Cornell University |
Multifunctional nucleic acid nano-structures
|
JP5529895B2
(ja)
|
2009-02-04 |
2014-06-25 |
ソンギュングヮン ユニバーシティ ファウンデーション フォー コーポレート コラボレーション |
細胞内の伝達能が増加した低分子干渉rna複合体
|
WO2010135716A1
(en)
|
2009-05-22 |
2010-11-25 |
The Research Foundation Of State University Of New York |
Trans-acting rna switches
|
ES2804764T3
(es)
*
|
2009-06-01 |
2021-02-09 |
Halo Bio Rnai Therapeutics Inc |
Polinucleótidos para la interferencia de ARN multivalente, composiciones y métodos de uso de los mismos
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US20130022649A1
(en)
|
2009-12-01 |
2013-01-24 |
Protiva Biotherapeutics, Inc. |
Snalp formulations containing antioxidants
|
WO2012170372A2
(en)
*
|
2011-06-08 |
2012-12-13 |
University Of Cincinnati |
Prna mutlivalent junction domain for use in stable multivalent rna nanoparticles
|
WO2014059022A1
(en)
*
|
2012-10-09 |
2014-04-17 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
|
JP6669655B2
(ja)
|
2013-09-17 |
2020-03-18 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
多機能rnaナノ粒子及び使用方法
|
AU2016312530A1
(en)
|
2015-08-24 |
2018-03-01 |
Halo-Bio Rnai Therapeutics, Inc. |
Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
|